phase readout
saveNCT04443829: Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma
ACTIVE_NOT_RECRUITINGupdated 2d ago
community read0 votes
Sponsor: University College, London. Phase: PHASE1. Conditions: Primary CNS Lymphoma
view source ↗
comments(0)
5-min edit window · permanent after that